カテゴリー： QYResearch, 世界

世界の軽度認知障害治療薬市場 2019年

【英語タイトル】Global Mild Cognitive Impairment Therapeutic Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X11443）・商品コード：DATA909X11443
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：112
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、軽度認知障害治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BAN-2401、ボスチニブ、ブレキサノロン、CSP-1103、その他に、用途別には、病院、クリニック、その他にセグメント区分し、軽度認知障害治療薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・軽度認知障害治療薬の世界市場概要
・軽度認知障害治療薬の製造コスト構成分析
・軽度認知障害治療薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・軽度認知障害治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・軽度認知障害治療薬のセグメント分析（種類別）
（BAN-2401、ボスチニブ、ブレキサノロン、CSP-1103、その他）
・軽度認知障害治療薬のセグメント分析（用途別）
（病院、クリニック、その他）
・軽度認知障害治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（AgeneBio Inc、Avraham Pharmaceuticals Ltd、CereSpir Inc、ConSynance Therapeutics Inc、Eisai Co Ltd、Eli Lilly and Company、Ensol Biosciences Inc、Genzyme Corp、IntelGenx Corp、Krenitsky Pharmaceuticals Inc、Merck & Co Inc、Nanotherapeutics Inc、Neuron Biopharma SA、Pfizer Inc、Sage Therapeutics Inc、SBI Pharmaceuticals Co Ltd、Suven Life Sciences Ltd、Takeda Pharmaceutical Company Ltd、Therapix Biosciences Ltd、）
・軽度認知障害治療薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Mild Cognitive Impairment Therapeutic market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Mild Cognitive Impairment Therapeutic volume and value at global level, regional level and company level. From a global perspective, this report represents overall Mild Cognitive Impairment Therapeutic market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Mild Cognitive Impairment Therapeutic in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Mild Cognitive Impairment Therapeutic manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AgeneBio Inc
Avraham Pharmaceuticals Ltd
CereSpir Inc
ConSynance Therapeutics Inc
Eisai Co Ltd
Eli Lilly and Company
Ensol Biosciences Inc
Genzyme Corp
IntelGenx Corp
Krenitsky Pharmaceuticals Inc
Merck & Co Inc
Nanotherapeutics Inc
Neuron Biopharma SA
Pfizer Inc
Sage Therapeutics Inc
SBI Pharmaceuticals Co Ltd
Suven Life Sciences Ltd
Takeda Pharmaceutical Company Ltd
Therapix Biosciences Ltd

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
BAN-2401
Bosutinib
Brexanolone
CSP-1103
Others

Segment by Application
Hospital
Clinic
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Mild Cognitive Impairment Therapeutic
1.1 Definition of Mild Cognitive Impairment Therapeutic
1.2 Mild Cognitive Impairment Therapeutic Segment by Type
1.2.1 Global Mild Cognitive Impairment Therapeutic Production Growth Rate Comparison by Types (2014-2025)
1.2.2 BAN-2401
1.2.3 Bosutinib
1.2.4 Brexanolone
1.2.5 CSP-1103
1.2.6 Others
1.3 Mild Cognitive Impairment Therapeutic Segment by Applications
1.3.1 Global Mild Cognitive Impairment Therapeutic Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Mild Cognitive Impairment Therapeutic Overall Market
1.4.1 Global Mild Cognitive Impairment Therapeutic Revenue (2014-2025)
1.4.2 Global Mild Cognitive Impairment Therapeutic Production (2014-2025)
1.4.3 North America Mild Cognitive Impairment Therapeutic Status and Prospect (2014-2025)
1.4.4 Europe Mild Cognitive Impairment Therapeutic Status and Prospect (2014-2025)
1.4.5 China Mild Cognitive Impairment Therapeutic Status and Prospect (2014-2025)
1.4.6 Japan Mild Cognitive Impairment Therapeutic Status and Prospect (2014-2025)
1.4.7 Southeast Asia Mild Cognitive Impairment Therapeutic Status and Prospect (2014-2025)
1.4.8 India Mild Cognitive Impairment Therapeutic Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Mild Cognitive Impairment Therapeutic
2.3 Manufacturing Process Analysis of Mild Cognitive Impairment Therapeutic
2.4 Industry Chain Structure of Mild Cognitive Impairment Therapeutic

3 Development and Manufacturing Plants Analysis of Mild Cognitive Impairment Therapeutic
3.1 Capacity and Commercial Production Date
3.2 Global Mild Cognitive Impairment Therapeutic Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Mild Cognitive Impairment Therapeutic
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Mild Cognitive Impairment Therapeutic Production and Capacity Analysis
4.2 Mild Cognitive Impairment Therapeutic Revenue Analysis
4.3 Mild Cognitive Impairment Therapeutic Price Analysis
4.4 Market Concentration Degree

5 Mild Cognitive Impairment Therapeutic Regional Market Analysis
5.1 Mild Cognitive Impairment Therapeutic Production by Regions
5.1.1 Global Mild Cognitive Impairment Therapeutic Production by Regions
5.1.2 Global Mild Cognitive Impairment Therapeutic Revenue by Regions
5.2 Mild Cognitive Impairment Therapeutic Consumption by Regions
5.3 North America Mild Cognitive Impairment Therapeutic Market Analysis
5.3.1 North America Mild Cognitive Impairment Therapeutic Production
5.3.2 North America Mild Cognitive Impairment Therapeutic Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Mild Cognitive Impairment Therapeutic Import and Export
5.4 Europe Mild Cognitive Impairment Therapeutic Market Analysis
5.4.1 Europe Mild Cognitive Impairment Therapeutic Production
5.4.2 Europe Mild Cognitive Impairment Therapeutic Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Mild Cognitive Impairment Therapeutic Import and Export
5.5 China Mild Cognitive Impairment Therapeutic Market Analysis
5.5.1 China Mild Cognitive Impairment Therapeutic Production
5.5.2 China Mild Cognitive Impairment Therapeutic Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Mild Cognitive Impairment Therapeutic Import and Export
5.6 Japan Mild Cognitive Impairment Therapeutic Market Analysis
5.6.1 Japan Mild Cognitive Impairment Therapeutic Production
5.6.2 Japan Mild Cognitive Impairment Therapeutic Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Mild Cognitive Impairment Therapeutic Import and Export
5.7 Southeast Asia Mild Cognitive Impairment Therapeutic Market Analysis
5.7.1 Southeast Asia Mild Cognitive Impairment Therapeutic Production
5.7.2 Southeast Asia Mild Cognitive Impairment Therapeutic Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Mild Cognitive Impairment Therapeutic Import and Export
5.8 India Mild Cognitive Impairment Therapeutic Market Analysis
5.8.1 India Mild Cognitive Impairment Therapeutic Production
5.8.2 India Mild Cognitive Impairment Therapeutic Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Mild Cognitive Impairment Therapeutic Import and Export

6 Mild Cognitive Impairment Therapeutic Segment Market Analysis (by Type)
6.1 Global Mild Cognitive Impairment Therapeutic Production by Type
6.2 Global Mild Cognitive Impairment Therapeutic Revenue by Type
6.3 Mild Cognitive Impairment Therapeutic Price by Type

7 Mild Cognitive Impairment Therapeutic Segment Market Analysis (by Application)
7.1 Global Mild Cognitive Impairment Therapeutic Consumption by Application
7.2 Global Mild Cognitive Impairment Therapeutic Consumption Market Share by Application (2014-2019)

8 Mild Cognitive Impairment Therapeutic Major Manufacturers Analysis
8.1 AgeneBio Inc
8.1.1 AgeneBio Inc Mild Cognitive Impairment Therapeutic Production Sites and Area Served
8.1.2 AgeneBio Inc Product Introduction, Application and Specification
8.1.3 AgeneBio Inc Mild Cognitive Impairment Therapeutic Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Avraham Pharmaceuticals Ltd
8.2.1 Avraham Pharmaceuticals Ltd Mild Cognitive Impairment Therapeutic Production Sites and Area Served
8.2.2 Avraham Pharmaceuticals Ltd Product Introduction, Application and Specification
8.2.3 Avraham Pharmaceuticals Ltd Mild Cognitive Impairment Therapeutic Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 CereSpir Inc
8.3.1 CereSpir Inc Mild Cognitive Impairment Therapeutic Production Sites and Area Served
8.3.2 CereSpir Inc Product Introduction, Application and Specification
8.3.3 CereSpir Inc Mild Cognitive Impairment Therapeutic Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 ConSynance Therapeutics Inc
8.4.1 ConSynance Therapeutics Inc Mild Cognitive Impairment Therapeutic Production Sites and Area Served
8.4.2 ConSynance Therapeutics Inc Product Introduction, Application and Specification
8.4.3 ConSynance Therapeutics Inc Mild Cognitive Impairment Therapeutic Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Eisai Co Ltd
8.5.1 Eisai Co Ltd Mild Cognitive Impairment Therapeutic Production Sites and Area Served
8.5.2 Eisai Co Ltd Product Introduction, Application and Specification
8.5.3 Eisai Co Ltd Mild Cognitive Impairment Therapeutic Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Eli Lilly and Company
8.6.1 Eli Lilly and Company Mild Cognitive Impairment Therapeutic Production Sites and Area Served
8.6.2 Eli Lilly and Company Product Introduction, Application and Specification
8.6.3 Eli Lilly and Company Mild Cognitive Impairment Therapeutic Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Ensol Biosciences Inc
8.7.1 Ensol Biosciences Inc Mild Cognitive Impairment Therapeutic Production Sites and Area Served
8.7.2 Ensol Biosciences Inc Product Introduction, Application and Specification
8.7.3 Ensol Biosciences Inc Mild Cognitive Impairment Therapeutic Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Genzyme Corp
8.8.1 Genzyme Corp Mild Cognitive Impairment Therapeutic Production Sites and Area Served
8.8.2 Genzyme Corp Product Introduction, Application and Specification
8.8.3 Genzyme Corp Mild Cognitive Impairment Therapeutic Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 IntelGenx Corp
8.9.1 IntelGenx Corp Mild Cognitive Impairment Therapeutic Production Sites and Area Served
8.9.2 IntelGenx Corp Product Introduction, Application and Specification
8.9.3 IntelGenx Corp Mild Cognitive Impairment Therapeutic Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Krenitsky Pharmaceuticals Inc
8.10.1 Krenitsky Pharmaceuticals Inc Mild Cognitive Impairment Therapeutic Production Sites and Area Served
8.10.2 Krenitsky Pharmaceuticals Inc Product Introduction, Application and Specification
8.10.3 Krenitsky Pharmaceuticals Inc Mild Cognitive Impairment Therapeutic Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Merck & Co Inc
8.12 Nanotherapeutics Inc
8.13 Neuron Biopharma SA
8.14 Pfizer Inc
8.15 Sage Therapeutics Inc
8.16 SBI Pharmaceuticals Co Ltd
8.17 Suven Life Sciences Ltd
8.18 Takeda Pharmaceutical Company Ltd
8.19 Therapix Biosciences Ltd

9 Development Trend of Analysis of Mild Cognitive Impairment Therapeutic Market
9.1 Global Mild Cognitive Impairment Therapeutic Market Trend Analysis
9.1.1 Global Mild Cognitive Impairment Therapeutic Market Size (Volume and Value) Forecast 2019-2025
9.2 Mild Cognitive Impairment Therapeutic Regional Market Trend
9.2.1 North America Mild Cognitive Impairment Therapeutic Forecast 2019-2025
9.2.2 Europe Mild Cognitive Impairment Therapeutic Forecast 2019-2025
9.2.3 China Mild Cognitive Impairment Therapeutic Forecast 2019-2025
9.2.4 Japan Mild Cognitive Impairment Therapeutic Forecast 2019-2025
9.2.5 Southeast Asia Mild Cognitive Impairment Therapeutic Forecast 2019-2025
9.2.6 India Mild Cognitive Impairment Therapeutic Forecast 2019-2025
9.3 Mild Cognitive Impairment Therapeutic Market Trend (Product Type)
9.4 Mild Cognitive Impairment Therapeutic Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Mild Cognitive Impairment Therapeutic Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Mild Cognitive Impairment Therapeutic
Table Global Mild Cognitive Impairment Therapeutic Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Mild Cognitive Impairment Therapeutic Production Market Share by Types in 2018
Figure BAN-2401 Product Picture
Figure Bosutinib Product Picture
Figure Brexanolone Product Picture
Figure CSP-1103 Product Picture
Figure Others Product Picture
Table Global Mild Cognitive Impairment Therapeutic Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Mild Cognitive Impairment Therapeutic Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Others
Figure Global Mild Cognitive Impairment Therapeutic Revenue (Million USD) (2014-2025)
Figure Global Mild Cognitive Impairment Therapeutic Production (K Pcs) (2014-2025)
Figure North America Mild Cognitive Impairment Therapeutic Market Size (Million USD) (2014-2025)
Figure Europe Mild Cognitive Impairment Therapeutic Market Size (Million USD) (2014-2025)
Figure China Mild Cognitive Impairment Therapeutic Market Size (Million USD) (2014-2025)
Figure Japan Mild Cognitive Impairment Therapeutic Market Size (Million USD) (2014-2025)
Figure Southeast Asia Mild Cognitive Impairment Therapeutic Market Size (Million USD) (2014-2025)
Figure India Mild Cognitive Impairment Therapeutic Market Size (Million USD) (2014-2025)
Table Mild Cognitive Impairment Therapeutic Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Mild Cognitive Impairment Therapeutic in 2018
Figure Manufacturing Process Analysis of Mild Cognitive Impairment Therapeutic
Figure Industry Chain Structure of Mild Cognitive Impairment Therapeutic
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Mild Cognitive Impairment Therapeutic Manufacturing Plants Distribution
Table Mild Cognitive Impairment Therapeutic Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Mild Cognitive Impairment Therapeutic Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Mild Cognitive Impairment Therapeutic Production (K Pcs) of Major Manufacturers (2014-2019)
Table Mild Cognitive Impairment Therapeutic Production Market Share of Major Manufacturers (2014-2019)
Figure Mild Cognitive Impairment Therapeutic Production Share by Manufacturers in 2018
Table Mild Cognitive Impairment Therapeutic Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Mild Cognitive Impairment Therapeutic Revenue Market Share of Major Manufacturers (2014-2019)
Figure Mild Cognitive Impairment Therapeutic Revenue Share by Manufacturers in 2018
Table Mild Cognitive Impairment Therapeutic Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Mild Cognitive Impairment Therapeutic Production by Regions 2014-2019 (K Pcs)
Table Global Mild Cognitive Impairment Therapeutic Production Market Share by Regions 2014-2019
Figure Global Mild Cognitive Impairment Therapeutic Production Market Share by Regions in 2018
Table Global Mild Cognitive Impairment Therapeutic Revenue by Regions 2014-2019 (Million USD)
Table Global Mild Cognitive Impairment Therapeutic Revenue Market Share by Regions 2014-2019
Figure Global Mild Cognitive Impairment Therapeutic Revenue Market Share by Regions in 2018
Table Global Mild Cognitive Impairment Therapeutic Consumption by Regions 2014-2019 (K Pcs)
Table Global Mild Cognitive Impairment Therapeutic Consumption Market Share by Regions 2014-2019
Figure North America Mild Cognitive Impairment Therapeutic Production Growth Rate 2014-2019 (K Pcs)
Figure North America Mild Cognitive Impairment Therapeutic Revenue Growth Rate 2014-2019 (Million USD)
Table North America Mild Cognitive Impairment Therapeutic Production, Consumption Import and Export (K Pcs)
Figure Europe Mild Cognitive Impairment Therapeutic Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Mild Cognitive Impairment Therapeutic Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Mild Cognitive Impairment Therapeutic Production, Consumption Import and Export (K Pcs)
Figure China Mild Cognitive Impairment Therapeutic Production Growth Rate 2014-2019 (K Pcs)
Figure China Mild Cognitive Impairment Therapeutic Revenue Growth Rate 2014-2019 (Million USD)
Table China Mild Cognitive Impairment Therapeutic Production, Consumption Import and Export (K Pcs)
Figure Japan Mild Cognitive Impairment Therapeutic Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Mild Cognitive Impairment Therapeutic Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Mild Cognitive Impairment Therapeutic Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Mild Cognitive Impairment Therapeutic Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Mild Cognitive Impairment Therapeutic Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Mild Cognitive Impairment Therapeutic Production, Consumption Import and Export (K Pcs)
Figure India Mild Cognitive Impairment Therapeutic Production Growth Rate 2014-2019 (K Pcs)
Figure India Mild Cognitive Impairment Therapeutic Revenue Growth Rate 2014-2019 (Million USD)
Table India Mild Cognitive Impairment Therapeutic Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Mild Cognitive Impairment Therapeutic Market Share by Application (2014-2019)
Figure Global Value (Consumption) Mild Cognitive Impairment Therapeutic Market Share by Application (2014-2019)
Table AgeneBio Inc Mild Cognitive Impairment Therapeutic Production Sites and Area Served
Table AgeneBio Inc Mild Cognitive Impairment Therapeutic Product Introduction, Application and Specification
Table AgeneBio Inc Mild Cognitive Impairment Therapeutic Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AgeneBio Inc Mild Cognitive Impairment Therapeutic Production Growth Rate (2014-2019)
Table AgeneBio Inc Mild Cognitive Impairment Therapeutic Production Market Share (2014-2019)
Figure AgeneBio Inc Mild Cognitive Impairment Therapeutic Revenue Market Share (2014-2019)
Table AgeneBio Inc Mild Cognitive Impairment Therapeutic Main Business and Markets Served
Table Avraham Pharmaceuticals Ltd Mild Cognitive Impairment Therapeutic Production Sites and Area Served
Table Avraham Pharmaceuticals Ltd Mild Cognitive Impairment Therapeutic Product Introduction, Application and Specification
Table Avraham Pharmaceuticals Ltd Mild Cognitive Impairment Therapeutic Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Avraham Pharmaceuticals Ltd Mild Cognitive Impairment Therapeutic Production Growth Rate (2014-2019)
Table Avraham Pharmaceuticals Ltd Mild Cognitive Impairment Therapeutic Production Market Share (2014-2019)
Figure Avraham Pharmaceuticals Ltd Mild Cognitive Impairment Therapeutic Revenue Market Share (2014-2019)
Table Avraham Pharmaceuticals Ltd Mild Cognitive Impairment Therapeutic Main Business and Markets Served
Table CereSpir Inc Mild Cognitive Impairment Therapeutic Production Sites and Area Served
Table CereSpir Inc Mild Cognitive Impairment Therapeutic Product Introduction, Application and Specification
Table CereSpir Inc Mild Cognitive Impairment Therapeutic Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table CereSpir Inc Mild Cognitive Impairment Therapeutic Production Growth Rate (2014-2019)
Table CereSpir Inc Mild Cognitive Impairment Therapeutic Production Market Share (2014-2019)
Figure CereSpir Inc Mild Cognitive Impairment Therapeutic Revenue Market Share (2014-2019)
Table CereSpir Inc Mild Cognitive Impairment Therapeutic Main Business and Markets Served
Table ConSynance Therapeutics Inc Mild Cognitive Impairment Therapeutic Production Sites and Area Served
Table ConSynance Therapeutics Inc Mild Cognitive Impairment Therapeutic Product Introduction, Application and Specification
Table ConSynance Therapeutics Inc Mild Cognitive Impairment Therapeutic Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table ConSynance Therapeutics Inc Mild Cognitive Impairment Therapeutic Production Growth Rate (2014-2019)
Table ConSynance Therapeutics Inc Mild Cognitive Impairment Therapeutic Production Market Share (2014-2019)
Figure ConSynance Therapeutics Inc Mild Cognitive Impairment Therapeutic Revenue Market Share (2014-2019)
Table ConSynance Therapeutics Inc Mild Cognitive Impairment Therapeutic Main Business and Markets Served
Table Eisai Co Ltd Mild Cognitive Impairment Therapeutic Production Sites and Area Served
Table Eisai Co Ltd Mild Cognitive Impairment Therapeutic Product Introduction, Application and Specification
Table Eisai Co Ltd Mild Cognitive Impairment Therapeutic Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eisai Co Ltd Mild Cognitive Impairment Therapeutic Production Growth Rate (2014-2019)
Table Eisai Co Ltd Mild Cognitive Impairment Therapeutic Production Market Share (2014-2019)
Figure Eisai Co Ltd Mild Cognitive Impairment Therapeutic Revenue Market Share (2014-2019)
Table Eisai Co Ltd Mild Cognitive Impairment Therapeutic Main Business and Markets Served
Table Eli Lilly and Company Mild Cognitive Impairment Therapeutic Production Sites and Area Served
Table Eli Lilly and Company Mild Cognitive Impairment Therapeutic Product Introduction, Application and Specification
Table Eli Lilly and Company Mild Cognitive Impairment Therapeutic Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eli Lilly and Company Mild Cognitive Impairment Therapeutic Production Growth Rate (2014-2019)
Table Eli Lilly and Company Mild Cognitive Impairment Therapeutic Production Market Share (2014-2019)
Figure Eli Lilly and Company Mild Cognitive Impairment Therapeutic Revenue Market Share (2014-2019)
Table Eli Lilly and Company Mild Cognitive Impairment Therapeutic Main Business and Markets Served
Table Ensol Biosciences Inc Mild Cognitive Impairment Therapeutic Production Sites and Area Served
Table Ensol Biosciences Inc Mild Cognitive Impairment Therapeutic Product Introduction, Application and Specification
Table Ensol Biosciences Inc Mild Cognitive Impairment Therapeutic Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ensol Biosciences Inc Mild Cognitive Impairment Therapeutic Production Growth Rate (2014-2019)
Table Ensol Biosciences Inc Mild Cognitive Impairment Therapeutic Production Market Share (2014-2019)
Figure Ensol Biosciences Inc Mild Cognitive Impairment Therapeutic Revenue Market Share (2014-2019)
Table Ensol Biosciences Inc Mild Cognitive Impairment Therapeutic Main Business and Markets Served
Table Genzyme Corp Mild Cognitive Impairment Therapeutic Production Sites and Area Served
Table Genzyme Corp Mild Cognitive Impairment Therapeutic Product Introduction, Application and Specification
Table Genzyme Corp Mild Cognitive Impairment Therapeutic Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Genzyme Corp Mild Cognitive Impairment Therapeutic Production Growth Rate (2014-2019)
Table Genzyme Corp Mild Cognitive Impairment Therapeutic Production Market Share (2014-2019)
Figure Genzyme Corp Mild Cognitive Impairment Therapeutic Revenue Market Share (2014-2019)
Table Genzyme Corp Mild Cognitive Impairment Therapeutic Main Business and Markets Served
Table IntelGenx Corp Mild Cognitive Impairment Therapeutic Production Sites and Area Served
Table IntelGenx Corp Mild Cognitive Impairment Therapeutic Product Introduction, Application and Specification
Table IntelGenx Corp Mild Cognitive Impairment Therapeutic Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table IntelGenx Corp Mild Cognitive Impairment Therapeutic Production Growth Rate (2014-2019)
Table IntelGenx Corp Mild Cognitive Impairment Therapeutic Production Market Share (2014-2019)
Figure IntelGenx Corp Mild Cognitive Impairment Therapeutic Revenue Market Share (2014-2019)
Table IntelGenx Corp Mild Cognitive Impairment Therapeutic Main Business and Markets Served
Table Krenitsky Pharmaceuticals Inc Mild Cognitive Impairment Therapeutic Production Sites and Area Served
Table Krenitsky Pharmaceuticals Inc Mild Cognitive Impairment Therapeutic Product Introduction, Application and Specification
Table Krenitsky Pharmaceuticals Inc Mild Cognitive Impairment Therapeutic Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Krenitsky Pharmaceuticals Inc Mild Cognitive Impairment Therapeutic Production Growth Rate (2014-2019)
Table Krenitsky Pharmaceuticals Inc Mild Cognitive Impairment Therapeutic Production Market Share (2014-2019)
Figure Krenitsky Pharmaceuticals Inc Mild Cognitive Impairment Therapeutic Revenue Market Share (2014-2019)
Table Krenitsky Pharmaceuticals Inc Mild Cognitive Impairment Therapeutic Main Business and Markets Served
Table Merck & Co Inc Mild Cognitive Impairment Therapeutic Production Sites and Area Served
Table Nanotherapeutics Inc Mild Cognitive Impairment Therapeutic Production Sites and Area Served
Table Neuron Biopharma SA Mild Cognitive Impairment Therapeutic Production Sites and Area Served
Table Pfizer Inc Mild Cognitive Impairment Therapeutic Production Sites and Area Served
Table Sage Therapeutics Inc Mild Cognitive Impairment Therapeutic Production Sites and Area Served
Table SBI Pharmaceuticals Co Ltd Mild Cognitive Impairment Therapeutic Production Sites and Area Served
Table Suven Life Sciences Ltd Mild Cognitive Impairment Therapeutic Production Sites and Area Served
Table Takeda Pharmaceutical Company Ltd Mild Cognitive Impairment Therapeutic Production Sites and Area Served
Table Therapix Biosciences Ltd Mild Cognitive Impairment Therapeutic Production Sites and Area Served
Figure Global Mild Cognitive Impairment Therapeutic Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Mild Cognitive Impairment Therapeutic Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Mild Cognitive Impairment Therapeutic Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Mild Cognitive Impairment Therapeutic Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Mild Cognitive Impairment Therapeutic Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Mild Cognitive Impairment Therapeutic Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Mild Cognitive Impairment Therapeutic Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Mild Cognitive Impairment Therapeutic Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Mild Cognitive Impairment Therapeutic Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Mild Cognitive Impairment Therapeutic Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Mild Cognitive Impairment Therapeutic Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Mild Cognitive Impairment Therapeutic Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Mild Cognitive Impairment Therapeutic Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Mild Cognitive Impairment Therapeutic Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Mild Cognitive Impairment Therapeutic Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Mild Cognitive Impairment Therapeutic by Type (2019-2025)
Table Global Consumption (K Pcs) of Mild Cognitive Impairment Therapeutic by Application (2019-2025)
Table Mild Cognitive Impairment Therapeutic Distributors List
Table Mild Cognitive Impairment Therapeutic Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

AgeneBio Inc、Avraham Pharmaceuticals Ltd、CereSpir Inc、ConSynance Therapeutics Inc、Eisai Co Ltd、Eli Lilly and Company、Ensol Biosciences Inc、Genzyme Corp、IntelGenx Corp、Krenitsky Pharmaceuticals Inc、Merck & Co Inc、Nanotherapeutics Inc、Neuron Biopharma SA、Pfizer Inc、Sage Therapeutics Inc、SBI Pharmaceuticals Co Ltd、Suven Life Sciences Ltd、Takeda Pharmaceutical Company Ltd、Therapix Biosciences Ltd、

★調査レポート[世界の軽度認知障害治療薬市場 2019年] (コード：DATA909X11443)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の軽度認知障害治療薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • ネットワーク障害エミュレーターの世界市場：規模・現状・予測2019-2025
    DATA909X18746 / QYResearch / 2019年11月25日 / ※当調査レポートでは、ネットワーク障害エミュレーターの世界市場について調査・分析し、ネットワーク障害エミュレーターの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ソフトウェアデファインドワイドエリアネットワーク（SD-WAN）、クラウド、モノのインターネット（IoT）、その他）、用途別（通信、政府防衛、BFSI、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のネットワーク障害エミュレーター市場動向 ・主要企業別マーケットシェア ・ネットワーク障害エミュレーターの種類別市場規模2014-2019 （ソフトウェアデファインドワイドエリアネットワーク（SD-WAN）、クラウド、モノのインターネット（IoT）、その他） ・ネットワーク障害エミュレーターの用途別市場規模2014-2019 （通信、政府防衛、BFSI、その他） ・ネットワーク障害エミュレーターの北米市場：主要企業・種類別/用途別市場規模 ・ネットワーク障害エミュレーターのヨーロッパ市場：主要企業・種類別/用途別市場規模...Network Impairment Emulators‎ provide such an environment in the virtual format for network performance and security testing, which can ensure the safety of networks and devices in any complicated condition. The Network Impairment Emulators‎ enable organizations to troubleshoot, design networks, test application performance, and optimize network performance. These factors drive the network emulator market.The global Network Impairment Emulators market size to grow from USD 146 million in 2019 to USD 217 million by 2024, at a Compound Annual Growth Rate (CAGR) of 8.1% during 2019–2024. In 2018, the global Network Impairment Emulators‎ market size was xx million US$ and it...
  • コグニティブ検索ツールの世界市場：規模・現状・予測2019-2025
    DATA909X18306 / QYResearch / 2019年11月25日 / ※当調査レポートでは、コグニティブ検索ツールの世界市場について調査・分析し、コグニティブ検索ツールの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（自然言語処理、画像処理）、用途別（IT、法律、マーケティング、顧客サービス、空港と港、銀行、テレコム、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のコグニティブ検索ツール市場動向 ・主要企業別マーケットシェア ・コグニティブ検索ツールの種類別市場規模2014-2019 （自然言語処理、画像処理） ・コグニティブ検索ツールの用途別市場規模2014-2019 （IT、法律、マーケティング、顧客サービス、空港と港、銀行、テレコム、その他） ・コグニティブ検索ツールの北米市場：主要企業・種類別/用途別市場規模 ・コグニティブ検索ツールのヨーロッパ市場：主要企業・種類別/用途別市場規模...Cognitive search is the new generation of enterprise search that uses artificial intelligence (AI) to return results that are more relevant to the user or embedded in an application issuing the search query and tools are software, service that used in cognitive searh.In 2018, the global Cognitive Search Tools market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Cognitive Search Tools status, future forecast, growth opportunity, key market and key players. The study objectives are to...
  • 世界の治療ワクチン市場 2019年
    DATA909X16392 / QYResearch / 2019年11月22日 / ※本調査レポートは、治療ワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ペプチド治療用ワクチン、細胞治療用ワクチン、核酸治療用ワクチンに、用途別には、腫瘍治療、B型肝炎、結核、単純ヘルペスウイルス、その他にセグメント区分し、治療ワクチンの世界市場を分析しました。 ・エグゼクティブ・サマリー ・治療ワクチンの世界市場概要 ・治療ワクチンの製造コスト構成分析 ・治療ワクチンの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・治療ワクチンの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・治療ワクチンのセグメント分析（種類別） （ペプチド治療用ワクチン、細胞治療用ワクチン、核酸治療用ワクチン）...The global Therapeutic Vaccines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Therapeutic Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Therapeutic Vaccines market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Therapeutic Vaccines in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Therapeutic Vaccines manufacturing...
  • 世界の治療的低体温システム市場 2019年
    DATA909X16388 / QYResearch / 2019年11月22日 / ※本調査レポートは、治療的低体温システムの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、冷却カテーテル、ウォーターブランケット、クールキャップ、その他に、用途別には、病院、救急ユニット、外来手術センター、その他にセグメント区分し、治療的低体温システムの世界市場を分析しました。 ・エグゼクティブ・サマリー ・治療的低体温システムの世界市場概要 ・治療的低体温システムの製造コスト構成分析 ・治療的低体温システムの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・治療的低体温システムの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・治療的低体温システムのセグメント分析（種類別） （冷却カテーテル、ウォーターブランケット、クールキャップ、その他）...The global Therapeutic Hypothermia Systems market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Therapeutic Hypothermia Systems volume and value at global level, regional level and company level. From a global perspective, this report represents overall Therapeutic Hypothermia Systems market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Therapeutic Hypothermia Systems in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の治療用超音波デバイス市場 2019年
    DATA909X16391 / QYResearch / 2019年11月22日 / ※本調査レポートは、治療用超音波デバイスの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、デスクトップ、ポータブルに、用途別には、病院治療、在宅ケア、その他にセグメント区分し、治療用超音波デバイスの世界市場を分析しました。 ・エグゼクティブ・サマリー ・治療用超音波デバイスの世界市場概要 ・治療用超音波デバイスの製造コスト構成分析 ・治療用超音波デバイスの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・治療用超音波デバイスの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・治療用超音波デバイスのセグメント分析（種類別） （デスクトップ、ポータブル）...The global Therapeutic Ultrasound Devices market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Therapeutic Ultrasound Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Therapeutic Ultrasound Devices market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Therapeutic Ultrasound Devices in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の閉塞性睡眠時無呼吸治療デバイス市場 2019年
    DATA909X12151 / QYResearch / 2019年11月20日 / ※本調査レポートは、閉塞性睡眠時無呼吸治療デバイスの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、PSG、パルスオキシメータに、用途別には、在宅ケアの設定、病院にセグメント区分し、閉塞性睡眠時無呼吸治療デバイスの世界市場を分析しました。 ・エグゼクティブ・サマリー ・閉塞性睡眠時無呼吸治療デバイスの世界市場概要 ・閉塞性睡眠時無呼吸治療デバイスの製造コスト構成分析 ・閉塞性睡眠時無呼吸治療デバイスの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・閉塞性睡眠時無呼吸治療デバイスの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・閉塞性睡眠時無呼吸治療デバイスのセグメント分析（種類別） （PSG、パルスオキシメータ）...The global Obstructive Sleep Apnea Therapeutic Device market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Obstructive Sleep Apnea Therapeutic Device volume and value at global level, regional level and company level. From a global perspective, this report represents overall Obstructive Sleep Apnea Therapeutic Device market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Obstructive Sleep Apnea Therapeutic Device in North America, Europe, China, Japan, Southeast Asia and...

    • ◆H&Iグローバルリサーチのお客様（例）◆